Based on the key role of CD8+ T cells in the anti-tumor immune responses, Sidi Chen group directly conducted genome scale CRISPR screen on CD8+ T cells in the context of cancer immunotherapy, and determined the key factors regulating tumor invasion and degranulation. The gene discussed is CD8A; the disease is neoplasm.